Literature DB >> 33925888

Low Hypoperfusion Intensity Ratio Is Associated with a Favorable Outcome Even in Large Ischemic Core and Delayed Recanalization Time.

Jang-Hyun Baek1,2, Young Dae Kim2,3, Ki Jeong Lee2,4, Jin Kyo Choi2,5, Minyoul Baik2, Byung Moon Kim6, Dong Joon Kim6, Ji Hoe Heo2,3, Hyo Suk Nam2,3.   

Abstract

In ischemic brain tissue, hypoperfusion severity can be assessed using the hypoperfusion intensity ratio (HIR). We evaluated the link between HIR and clinical outcomes after successful recanalization by endovascular treatment. We retrospectively reviewed 162 consecutive patients who underwent endovascular treatment for intracranial large vessel occlusion. The HIR was calculated using an automated software program, with initial computed tomography perfusion images. The HIR was compared between patients with and without favorable outcomes. To observe the modifying effect of the HIR on the well-known major outcome determinants, regression analyses were performed in the low and high HIR groups. The median HIR value was significantly lower in patients with a favorable outcome, with an optimal cut-off point of 0.54. The HIR was an independent factor for a favorable outcome in a specific multivariable model and was significantly correlated with the Alberta Stroke Program Early Computed Tomography Score (ASPECTS). In contrast to the high HIR group, the low HIR group showed that ASPECTS and onset-to-recanalization time were not independently associated with a favorable outcome. Finally, the low HIR group had a more favorable outcome even in cases with an unfavorable ASPECTS and onset-to-recanalization time. The HIR could be useful in predicting outcomes after successful recanalization.

Entities:  

Keywords:  collaterality; hypoperfusion; outcome; stroke; thrombectomy

Year:  2021        PMID: 33925888     DOI: 10.3390/jcm10091869

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  19 in total

1.  Blood Pressure Drop and Penumbral Tissue Loss in Nonrecanalized Emergent Large Vessel Occlusion.

Authors:  Han-Gil Jeong; Beom Joon Kim; Hyeran Kim; Cheolkyu Jung; Moon-Ku Han; David S Liebeskind; Hee-Joon Bae
Journal:  Stroke       Date:  2019-08-29       Impact factor: 7.914

2.  Hyperintense Vessels on FLAIR: Hemodynamic Correlates and Response to Thrombolysis.

Authors:  A Kufner; I Galinovic; V Ambrosi; C H Nolte; M Endres; J B Fiebach; M Ebinger
Journal:  AJNR Am J Neuroradiol       Date:  2015-05-14       Impact factor: 3.825

3.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score.

Authors:  P A Barber; A M Demchuk; J Zhang; A M Buchan
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

4.  Hypoperfusion Intensity Ratio Is Correlated With Patient Eligibility for Thrombectomy.

Authors:  Adrien Guenego; David G Marcellus; Blake W Martin; Soren Christensen; Gregory W Albers; Maarten G Lansberg; Michael P Marks; Max Wintermark; Jeremy J Heit
Journal:  Stroke       Date:  2019-04       Impact factor: 7.914

5.  Hypoperfusion intensity ratio correlates with angiographic collaterals in acute ischaemic stroke with M1 occlusion.

Authors:  A Guenego; R Fahed; G W Albers; G Kuraitis; E S Sussman; B W Martin; D G Marcellus; J-M Olivot; M P Marks; M G Lansberg; M Wintermark; J J Heit
Journal:  Eur J Neurol       Date:  2020-03-13       Impact factor: 6.089

Review 6.  Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  Shadi Yaghi; Joshua Z Willey; Brett Cucchiara; Joshua N Goldstein; Nicole R Gonzales; Pooja Khatri; Louis J Kim; Stephan A Mayer; Kevin N Sheth; Lee H Schwamm
Journal:  Stroke       Date:  2017-11-02       Impact factor: 7.914

7.  Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemiczzm321990Core Growth but Not Neurologic Outcome

Authors:  Adam de Havenon; Michael Mlynash; May A Kim-Tenser; Maarten G Lansberg; Thalabe Leslie-Mazwi; Soren Christensen; Ryan A McTaggart; Matthew Alexander; Gregory Albers; Joseph Broderick; Michael P Marks; Jeremy J Heit
Journal:  Stroke       Date:  2019-03       Impact factor: 7.914

8.  Natural course of total mismatch and predictors for tissue infarction.

Authors:  Benjamin Hotter; Ann-Christin Ostwaldt; Anastasia Levichev-Connolly; Michal Rozanski; Heinrich J Audebert; Jochen B Fiebach
Journal:  Neurology       Date:  2015-07-31       Impact factor: 9.910

9.  CT Angiography of Collateral Vessels and Outcomes in Endovascular-Treated Acute Ischemic Stroke Patients.

Authors:  Beom Joon Kim; Jong Won Chung; Hong Kyun Park; Jun Yup Kim; Mi Hwa Yang; Moon Ku Han; Cheolkyu Jeong; Gyojun Hwang; O Ki Kwon; Hee Joon Bae
Journal:  J Clin Neurol       Date:  2017-01-12       Impact factor: 3.077

10.  Predictors of Good Outcomes in Patients with Failed Endovascular Thrombectomy.

Authors:  Hyungjong Park; Byung Moon Kim; Jang Hyun Baek; Jun Hwee Kim; Ji Hoe Heo; Dong Joon Kim; Hyo Suk Nam; Young Dae Kim
Journal:  Korean J Radiol       Date:  2020-05       Impact factor: 3.500

View more
  2 in total

1.  Prognostic Accuracy of CTP Summary Maps in Patients with Large Vessel Occlusive Stroke and Poor Revascularization after Mechanical Thrombectomy-Comparison of Three Automated Perfusion Software Applications.

Authors:  Iris Muehlen; Matthias Borutta; Gabriela Siedler; Tobias Engelhorn; Stefan Hock; Michael Knott; Philip Hoelter; Bastian Volbers; Stefan Schwab; Arnd Doerfler
Journal:  Tomography       Date:  2022-05-17

2.  Cerebral Hypoperfusion Intensity Ratio Is Linked to Progressive Early Edema Formation.

Authors:  Noel van Horn; Gabriel Broocks; Reza Kabiri; Michel C Kraemer; Soren Christensen; Michael Mlynash; Lukas Meyer; Maarten G Lansberg; Gregory W Albers; Peter Sporns; Adrien Guenego; Jens Fiehler; Max Wintermark; Jeremy J Heit; Tobias D Faizy
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.